Omid Holdings (Omid Holdings) Capex-to-Revenue : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Omid Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Omid Holdings's Capital Expenditure for the three months ended in . 20 was $0.00 Mil. Its Revenue for the three months ended in . 20 was $0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.

Omid Holdings Capex-to-Revenue Historical Data

The historical data trend for Omid Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omid Holdings Capex-to-Revenue Chart

Omid Holdings Annual Data

Trend

Capex-to-Revenue

Omid Holdings Quarterly Data

Capex-to-Revenue

Competitive Comparison of Omid Holdings's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Omid Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Omid Holdings's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Omid Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Omid Holdings's Capex-to-Revenue falls into.

Omid Holdings Capex-to-Revenue Calculation

Omid Holdings's Capex-to-Revenue for the fiscal year that ended in . 20 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- ()	/
	=	N/A

Omid Holdings's Capex-to-Revenue for the quarter that ended in . 20 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- ()	/
	=	N/A

Omid Holdings (OTCPK:OMID) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Omid Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Omid Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Omid Holdings (Omid Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Omid Holdings Inc (OTCPK:OMID) » Definitions » Capex-to-Revenue

Traded in Other Exchanges

N/A

Address

1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865

Website

https://www.omidholdingsinc.com

Omid Holdings Inc is a health and wellness company. It is specialized in the sale and manufacture of CBD-based products. The company manufactures and sells branded inhalable, sublingual, and topical hemp-derived consumer goods. Its brands include Naturally Peaked Health, Shangri-La Life, and Peac Wellness. The company also offers design, development, manufacturing services to clients in the CBD-based cannabis industry.